Cedars Sinai Medical Center
8700 Beverly Blvd
1090 Davis Building
Los Angeles, CA 90048
After a heart attack, many heart muscle cells dye and a scar forms, leaving the injured heart cannot pump blood properly. Unlike other organs, such as intestine and liver, the heart's capability to regenerate itself is limited. My lab is interesting in using stem cells (especially heart-derived cells) and biomaterials to restore heart function. For stem cell translational research, my lab has been focused on cardiosphere-derived stem cells (CDCs), studying their origins and testing their therapeutic potential in animal models and human beings. I served as the Director of Stem Cell Manufacturing for the recently completed CADUCEUS trial utilizing patient-derived autologous CDCs to treat ischemic heart diseases. For bioengineering techniques, we use a combination of magnetic/molecular targeting, tissue engineering, nanotechnologies, biodegradable polymers, and imaging technologies to better understand stem cell biology in vitro and in vivo, and develop more potent therapies for ischemic heart diseases. For fundamental researches, my lab is fascinated by questions such as: how bloodborn stem cells cross the vessel wall and reach the parenchyma; how cell-cell contact can reprogram injured cardiovascular cells to mediate endogenous rejuvenation/repair; how microRNAs involve in cardiac protection and regeneration.
For stem cell translational research, my lab has been focused on cardiosphere-derived stem cells (CDCs), studying their origins and testing their therapeutic potential in animal models and human beings. I served as the Director of Stem Cell Manufacturing for the recently completed CADUCEUS trial utilizing patient-derived autologous CDCs to treat ischemic heart diseases. For bioengineering techniques, we use a combination of magnetic/molecular targeting, tissue engineering, nanotechnologies, biodegradable polymers, and imaging technologies to better understand stem cell biology in vitro and in vivo, and develop more potent therapies for ischemic heart diseases. For fundamental researches, my lab is fascinated by questions such as: how bloodborn stem cells cross the vessel wall and reach the parenchyma; how cell-cell contact can reprogram injured cardiovascular cells to mediate endogenous rejuvenation/repair; how microRNAs involve in cardiac protection and regeneration.
Dr. Ke Cheng is a stem cell biologist and biomedical engineer who has served on the UCLA School of Medicine faculty since he joined the Department of Medicine in 2010. Dr. Cheng is also a faculty member and Director of Cardiac Stem Cell Manufacturing at the Cedars-Sinai Heart Institute, where his lab is located. Dr. Cheng earned his B.S. in Pharmaceutical Engineering at Zhejiang University in China and Ph.D. in Biological Engineering at the University of Georgia, Athens. His lab studies regenerative medicine strategies with a particular focus on stem cells, biomaterials and bioengineering approaches to heart regeneration.
Does this profile need updating? Contact Us